Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.56 |
| ▸ | FBP1 | P09467 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | TTR | P02766 | 1/20 | 0.46 |
| ▸ | PIM1 | P11309 | 1/20 | 0.46 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.46 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.46 |
| ▸ | P4HB | P07237 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3237563 | 0.84 | NFE2L2 (0.58) | NFE2L2FBP1TSHRMAPK1MEN1 | |
| SCHEMBL5963737 | 0.83 | NFE2L2 (0.62) | NFE2L2FBP1TSHRMAPK1MEN1 | |
| SCHEMBL5537772 | 0.82 | NFE2L2 (0.56) | NFE2L2FBP1TSHRMAPK1MEN1 | |
| SCHEMBL543469 | 0.80 | NFE2L2 (0.59) | NFE2L2FBP1TSHRMAPK1MEN1 | |
| SCHEMBL15741569 | 0.80 | NFE2L2 (0.55) | NFE2L2FBP1TSHRMAPK1MEN1 | |
| SCHEMBL5537770 | 0.80 | NFE2L2 (0.55) | NFE2L2FBP1TSHRMAPK1MEN1 | |
| SCHEMBL127539 | 0.80 | NFE2L2 (0.55) | NFE2L2FBP1TSHRMAPK1MEN1 | |
| SCHEMBL13790316 | 0.80 | NFE2L2 (0.82) | NFE2L2FBP1TSHRMAPK1MEN1 | |
| SCHEMBL67201 | 0.80 | FBP1 (0.56) | NFE2L2FBP1TSHRMAPK1MEN1 | |
| SCHEMBL216267 | 0.80 | NFE2L2 (0.55) | NFE2L2FBP1TSHRMAPK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102459234-B | Substituted benzotriazines and quinoxalines as P70S6 kinase inhibitors | SENTINEL ONCOLOGY LTD. (GB) | 2014-10-15 | — | — | CN | claimed |
| CN-101801949-B | Sulfonamides as TRPM8 modulators | JANSSEN PHARMACEUTICA NV | 2014-09-24 | — | — | CN | claimed |
| EP-2183239-A1 | SULFONAMIDES AS TRPM8 MODULATORS | Janssen Pharmaceutica, N.V. (BE) | 2010-05-12 | — | — | EP | claimed |
| WO-2009012430-A1 | SULFONAMIDES AS TRPM8 MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2009-01-22 | — | — | WO | claimed |
| WO-2006002022-A2 | COMPOSITIONS AND METHODS USEFUL FOR THE TREATMENT OF HYPERGLYCEMIA | IMMUSOL INCORPORATED (US) | 2006-01-05 | — | — | WO | claimed |
| CN-102459234-B | Substituted benzotriazines and quinoxalines as P70S6 kinase inhibitors | SENTINEL ONCOLOGY LTD. (GB) | 2014-10-15 | — | — | CN | disclosed |
| CN-102203060-B | 3-(benzylamino)-pyrrolidine derivatives and their use as nk-3 receptor antagonists | HOFFMANN LA ROCHE | 2014-09-24 | — | — | CN | disclosed |
| CN-101801949-B | Sulfonamides as TRPM8 modulators | JANSSEN PHARMACEUTICA NV | 2014-09-24 | — | — | CN | disclosed |
| CN-102099032-B | Methods of treating alpha adrenergic mediated conditions | ALLERGAN INC | 2014-07-09 | — | — | CN | disclosed |
| CN-102325763-B | Sulfamides as TRPM8 modulators | JANSSEN PHARMACEUTICA NV | 2014-01-29 | — | — | CN | disclosed |
| CN-103497188-A | Compounds modulating c-fms and/or c-kit activity and uses therefor | PLEXXIKON INC | 2014-01-08 | — | — | CN | disclosed |
| CN-101605787-B | Compounds that modulate c-fms and/or c-kit activity and uses thereof | PLEXXIKON INC | 2013-11-13 | — | — | CN | disclosed |
| CN-101959516-B | Combination therapy comprising quinoxaline PI3K alpha inhibitors for the treatment of cancer | EXELIXIS INC | 2013-05-08 | — | — | CN | disclosed |
| EP-2414330-A2 | PIPERIDINE AND PIPERAZINE DERIVATIVES AS AUTOTAXIN INHIBITORS | Merck Patent GmbH (DE) | 2012-02-08 | — | — | EP | disclosed |
| WO-2010115491-A2 | PIPERIDINE AND PIPERAZINE DERIVATIVES AS AUTOTAXIN INHIBITORS | MERCK PATENT GMBH (DE) | 2010-10-14 | — | — | WO | disclosed |
| EP-2183239-A1 | SULFONAMIDES AS TRPM8 MODULATORS | Janssen Pharmaceutica, N.V. (BE) | 2010-05-12 | — | — | EP | disclosed |
| EP-2061789-A2 | THIADIAZOLE COMPOUND AND USE THEREOF | Sumitomo Chemical Company, Limited (JP) | 2009-05-27 | — | — | EP | disclosed |
| WO-2009012430-A1 | SULFONAMIDES AS TRPM8 MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2009-01-22 | — | — | WO | disclosed |
| WO-2008032858-A2 | THIADIAZOLE COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-03-20 | — | — | WO | disclosed |
| WO-2006002022-A2 | COMPOSITIONS AND METHODS USEFUL FOR THE TREATMENT OF HYPERGLYCEMIA | IMMUSOL INCORPORATED (US) | 2006-01-05 | — | — | WO | disclosed |